Antithrombotic agent usage before ictus in aneurysmal subarachnoid hemorrhage: relation to hemorrhage severity, clinical course, and outcome

[1]  T. Howells,et al.  NT-proBNP and troponin I in high-grade aneurysmal subarachnoid hemorrhage: Relation to clinical course and outcome. , 2022, Journal of critical care.

[2]  A. Lewén,et al.  Intracranial pressure- and cerebral perfusion pressure threshold-insults in relation to cerebral energy metabolism in aneurysmal subarachnoid hemorrhage , 2022, Acta Neurochirurgica.

[3]  A. Lewén,et al.  Pre-injury antithrombotic agents predict intracranial hemorrhagic progression, but not worse clinical outcome in severe traumatic brain injury , 2021, Acta Neurochirurgica.

[4]  A. Lewén,et al.  Low intracranial pressure variability is associated with delayed cerebral ischemia and unfavorable outcome in aneurysmal subarachnoid hemorrhage , 2021, Journal of Clinical Monitoring and Computing.

[5]  A. Lewén,et al.  Temporal Dynamics of ICP, CPP, PRx, and CPPopt in High-Grade Aneurysmal Subarachnoid Hemorrhage and the Relation to Clinical Outcome , 2021, Neurocritical Care.

[6]  P. Willems,et al.  Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial , 2020, The Lancet.

[7]  W. Vandertop,et al.  Platelet transfusion in patients with aneurysmal subarachnoid hemorrhage is associated with poor clinical outcome , 2020, Scientific Reports.

[8]  V. Seifert,et al.  Vitamin K Antagonist (Phenprocoumon) and Subarachnoid Hemorrhage: A Single-Center, Matched-Pair Analysis , 2019, Neurocritical Care.

[9]  J. Simard,et al.  Utility of the Hijdra Sum Score in Predicting Risk of Aneurysm in Patients With Subarachnoid Hemorrhage: A Single-Center Experience With 550 Patients. , 2019, Neurosurgery.

[10]  A. Molyneux,et al.  Prediction of Outcome After Aneurysmal Subarachnoid Hemorrhage: Development and Validation of the SAFIRE Grading Scale , 2019, Stroke.

[11]  T. Cai,et al.  Association between aspirin dose and subarachnoid hemorrhage from saccular aneurysms , 2018, Neurology.

[12]  V. Seifert,et al.  Continuous Acetylsalicylic Acid Treatment Does Not Influence Bleeding Pattern or Outcome of Aneurysmal Subarachnoid Hemorrhage: A Matched-Pair Analysis. , 2018, World neurosurgery.

[13]  A. Lewén,et al.  Effect of HHH-Therapy on Regional CBF after Severe Subarachnoid Hemorrhage Studied by Bedside Xenon-Enhanced CT , 2017, Neurocritical Care.

[14]  J. Teitelbaum,et al.  Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: Executive Summary. A Statement for Healthcare Professionals From the Neurocritical Care Society and the Society of Critical Care Medicine , 2016, Critical care medicine.

[15]  E. Grove,et al.  Sixteen-year nationwide trends in antithrombotic drug use in Denmark and its correlation with landmark studies , 2016, Heart.

[16]  Rustam Al-Shahi Salman,et al.  Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial , 2016, The Lancet.

[17]  Soojin Park,et al.  Prognostication of long‐term outcomes after subarachnoid hemorrhage: The FRESH score , 2016, Annals of neurology.

[18]  O. Sakowitz,et al.  Anticoagulation Reversal with Prothrombin Complex Concentrate in Aneurysmal Subarachnoid Hemorrhage. , 2015, The Journal of emergency medicine.

[19]  G. Luijckx,et al.  Predictive Factors for Rebleeding After Aneurysmal Subarachnoid Hemorrhage: Rebleeding Aneurysmal Subarachnoid Hemorrhage Study , 2015, Stroke.

[20]  J. Hallas,et al.  Antithrombotic drugs and subarachnoid haemorrhage risk , 2015, Thrombosis and Haemostasis.

[21]  D. Ding,et al.  Potential Role of Aspirin in the Prevention of Aneurysmal Subarachnoid Hemorrhage , 2015, Cerebrovascular Diseases.

[22]  S. Behr,et al.  Risk of Subarachnoid Hemorrhage and Early Case Fatality Associated With Outpatient Antithrombotic Drug Use , 2013, Stroke.

[23]  Robert D. Brown,et al.  Aspirin as a Promising Agent for Decreasing Incidence of Cerebral Aneurysm Rupture , 2011, Stroke.

[24]  P. Higgins,et al.  Aspirin resistance and compliance with therapy. , 2011, Cardiovascular therapeutics.

[25]  A. Algra,et al.  Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage , 2011, The Lancet Neurology.

[26]  W. Niessen,et al.  Platelet aggregation inhibitors, vitamin K antagonists and risk of subarachnoid hemorrhage , 2011, Journal of thrombosis and haemostasis : JTH.

[27]  D. Nichols,et al.  Influence of aspirin on outcome following aneurysmal subarachnoid hemorrhage. , 2004, Journal of neurosurgery.

[28]  H. Quan,et al.  New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. , 2004, Journal of clinical epidemiology.

[29]  J. Hillman,et al.  Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study. , 2002, Journal of neurosurgery.

[30]  B Jennett,et al.  Analyzing outcome of treatment of severe head injury: a review and update on advancing the use of the Glasgow Outcome Scale. , 1998, Journal of neurotrauma.

[31]  G. Teasdale,et al.  Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use. , 1998, Journal of neurotrauma.

[32]  A. Algra,et al.  Outcome of aneurysmal subarachnoid hemorrhage in patients on anticoagulant treatment. , 1997, Stroke.

[33]  J. van Gijn,et al.  Grading the amount of blood on computed tomograms after subarachnoid hemorrhage. , 1990, Stroke.

[34]  Fisher Cm,et al.  Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. , 1980, Neurosurgery.